Skip to main content

Inspection visit

Inspection

CYPRESS POINTE HEALTH CAMPUSCMS #3663841 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on resident and staff interviews, and record review, the facility failed to ensure medications were supplied by the pharmacy to be administered per physician order. This affected one (Resident #1) of three residents reviewed for medications. The facility census was 67. Findings include: Record review for Resident #1 revealed the resident was admitted to the facility on [DATE]. Diagnoses for Resident #1 included intervertebral disc disorder, arthritis, asthma, and chronic pain. Review of the comprehensive Minimum Data Set (MDS) assessment dated [DATE] revealed Resident #1 had intact cognition. Review of Resident #1's care plans dated 07/2023 revealed a focus for resident exhibiting a verbal difficulty with compliance of medication administration. Interventions included assessing for unmet needs, assist the resident with comprehension of policies and regulations, determine cause for behaviors, and observe for triggers to behaviors. Review of the physician orders revealed on 06/30/23, Resident #1 was ordered to receive Humira (immunosuppressive) 40 milligrams (mg) per 0.8 milliliter (ml) subcutaneous injection once a day every two weeks on Friday. Review of the Medication Administration Records (MAR) dated 06/2023 revealed Resident #1 received the Humira shot on 06/30/23 per physician order. On 07/14/23, Resident #1 received one dose of the Humira shot. On 07/28/23, Resident #1 did not receive the Humira shot for the reason charted as 'drug item unavailable, pharmacy to send'. On the 08/11/23, Resident #1 did not receive the Humira shot for the reason documented as 'drug unavailable, pharmacy notified of need to supply-resident to supply'. On 8/25/23, the Humira shot was not administered for the reason documented 'drug unavailable'. On 09/08/23, Resident #1 received the Humira shot per physician order. On 09/22/23, Resident #1 did not receive the Humira shot scheduled for the reason documented 'drug unavailable'. On 10/06/23, Resident #1 did not receive the Humira shot scheduled for the reason documented as 'drug unavailable'. Resident #1 received Humira three times out of eight opportunities. Interview on 10/11/23 at 2:30 P.M. with Resident #1 revealed the resident admitted to having medications from her personal pharmacy brought into the facility. Resident #1 stated she was upset because every time her Humira shot was due, the nurses would tell her it was unavailable. Resident #1 stated she did have her family bring her a Humira shot to her, and she was caught by the nurse with the medication. Resident #1 stated she only was taking the medication herself because she did not believe (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 366384 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366384 B. Wing A. Building (X3) DATE SURVEY COMPLETED 10/16/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Cypress Pointe Health Campus 600 West National Road Englewood, OH 45322 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few the facility would supply her with her medication. Resident #1 verified prior to 06/2023, her medications were being supplied as ordered. Interview on 10/16/23 at 11:30 A.M. with the Director of Nursing (DON) revealed Resident #1 often refused medications and would have her family bring in medications from home for her to administer to herself. The DON stated the facility staff educated the resident frequently on how important it was to only take the medications from the facility per order. The DON stated the resident was found to be administering the Humira shot herself at times. The DON stated the resident's personal pharmacy had supplied some of the Humira medications. The DON verified there was missing scheduled doses of the Humira on the reviewed MARs for Resident #1. Interview on 10/16/23 at 3:00 P.M. with the Regional Support (RS) #400 stated he was able to get a pharmacy invoice for Resident #1's Humira medications from her personal pharmacy. The resident's pharmacy had supplied the Humira medications since 11/2022, upon the resident's admission. RS #400 stated he was unsure of how Resident #1 would have gotten the Humira shot to administer to herself unless her family was bringing in the medications and giving them to the resident. RS #400 stated there were no facility pharmacy invoices for Resident #1's Humira medication and there was no evidence the facility pharmacy had supplied any of the Humira while the resident was residing in the facility. RS #400 stated Resident #1 was non-compliant with medications and would often have her family bring in medications not on her medications lists and she would take the medications as she wanted. RS #400 stated the facility staff tried to educate the resident on the importance of not taking medications herself. RS #400 verified there was documentation on the 06/2023, 07/2023, 08/2023, 09/2023, and 10/2023 MARS that the Humira shot was administered and not available for administration. RS #400 verified the only documentation of the resident giving herself the medication was the nursing progress note dated 08/01/23. This deficiency represents non-compliance investigated under Complaint Number OH00146459. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 366384 If continuation sheet Page 2 of 2

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0755GeneralS&S Dpotential for harm

    F755 - Pharmacy Services

    Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist.

FAQ · About this visit

Common questions about this visit

What happened during the October 16, 2023 survey of CYPRESS POINTE HEALTH CAMPUS?

This was a inspection survey of CYPRESS POINTE HEALTH CAMPUS on October 16, 2023. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at CYPRESS POINTE HEALTH CAMPUS on October 16, 2023?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharm..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.